The Board of Directors announce
Ex-rights and dividend record date.
Date of events
2022/08/12
To which item it meets
paragraph 14
Statement
1.Date of the resolution by the board of directors or shareholders meeting
or decision by the Company:2022/08/12
2.Type of ex-rights or ex-dividend (please enter: "Ex-rights",
"Ex-dividend", or "Ex-rights and dividend"):Ex-rights and dividend
3.Type and monetary amount of dividend distribution:
Cash dividends of common shares NT$913,362,083,NT$1 Per share
Stock dividends of common shares NT$91,336,200,NT$0.1 Per share
4.Ex-rights (ex-dividend) trading date:2022/09/08
5.Last date before book closure:2022/09/12
6.Book closure starting date:2022/09/13
7.Book closure ending date:2022/09/17
8.Ex-rights (ex-dividend) record date:2022/09/17
9.Any other matters that need to be specified:
(1)The preliminary scheduled distribution date of the capital increase
and cash dividends is 2022/10/14.
(2)If number of outstanding common stock shares are changed due to
change of share capital causing dividend payout ratio and price of
convertible corporate bonds to change, the Chairman be authorized
to handle these.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Mercuries & Associates Holding Ltd. published this content on 12 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 August 2022 08:09:06 UTC.
MERCURIES & ASSOCIATES, HOLDINGS LTD. is a Taiwan-based investment holding company principally engaged in life insurance businesses. The Company operates through four businesses. The Retail of Daily Commodities and Food businesses include the trading of garments, accessories, toys, medical supplies, infant products, jewelries, glasses and porcelains, as well as the provision of fast food. The Life Insurance businesses include personal insurance, personal health insurance, personal accident insurance, personal pension insurance and group insurance, among others. Pharmaceuticals businesses include the manufacture of active pharmaceutical ingredients (API), API intermediates and specialized chemicals. Other businesses include financial businesses, system integration businesses and engineering repair and maintenance businesses, among others.